Fosun: Initiate at OP; Discipline Fuels Resilience
Pius Xue, CFA - Senior Analyst, CreditSights
Zoey Zhou Qianyun, CFA - Analyst, East Asia Corporates, CreditSights
27 November 2025
Insights into Fosun International credit analysis, including:
- Diversified Investment Portfolio Strategy: Discover how Fosun International’s credit profile benefits from a well-balanced portfolio across health, happiness, wealth, and intelligent manufacturing segments, with 53% of revenue generated overseas and low single-name concentration risk.
- Holdco-Level Liquidity Assessment: Learn how our Fosun International credit analysis evaluates the holding company’s capital structure, including RMB 89 bn in debt as of 1H25, with 74% from bank loans and improving access to both onshore and offshore capital markets.
- Core Asset Performance Review: Explore detailed financial metrics for Fosun’s key investments including Fosun Pharma (15% of portfolio value), BCP (12%), Fidelidade (10%), and Yuyuan (8%), with comprehensive analysis of their operational resilience and credit metrics.
- Asset Monetization Capability: See how Fosun has realized approximately RMB 71 bn through strategic disposals since FY22, demonstrating strong ability and willingness to optimize portfolio composition and manage leverage at the holdco level.
- Loan-to-Value Coverage Analysis: Gauge Fosun’s moderate leverage position with a 40.4% LTV ratio as of 1H25, supported by our comprehensive portfolio valuation methodology that accounts for both listed (43%) and unlisted (57%) holdings across multiple geographies.
Executive Summary
-
We expect Fosun International’s credit metrics to remain supported by the stable to improving performance of its core investments in FY26, alongside gradual deleveraging through non-core asset disposals in the medium term; on a relative value basis, its $ bonds offer value compared to China BB-rated peers and broader Asia HY investment holding names, and can see potential for spreads to tighten by 30 bp.
-
Fosun is a Hong Kong incorporated investment holding company listed on the Hong Kong Stock Exchange since 2007; it is 73% held by Fosun Holdings, which is in turn controlled by Guo Guangchang, co-founder and chairman, and Wang Qunbin, co-founder and co-chairman.
-
Fosun has four business segments – health, happiness, wealth (insurance and asset management) and intelligent manufacturing; it operates as an investment holding company, making strategic decisions on acquisitions, divestments and financing over its portfolio assets.
-
We (1) valued Fosun’s portfolio assets as part of the loan-to-value analysis, (2) analyzed its key assets, including Fosun Pharma, Yuyuan, Fosun Tourism Group, Fidelidade, Banco Comercial Português, Peak Reinsurance, and Hainan Mining, and (3) reviewed its holding company-level capital structure and liquidity.
-
Fosun’s credit profile is underpinned by diversified investment portfolio across sectors and geographies, improving access to bank and capital markets, as well as the strong ability and willingness to monetize assets; these strengths mitigate concerns over its volatile income stream and heavy reliance on short-term financing, volatility in portfolio value on mark-to-market of listed assets, lack of transparency around unlisted portfolio assets, underperformance of certain subsidiaries/investments, as well as key man risk.



